Navigation Links
MedBox Develops Patent-Pending System for Storage and Retrieval of Prescription Drugs

HOLLYWOOD, Calif., Nov. 16, 2011 /PRNewswire/ -- MedBox (Pink Sheets: MDBX) ( announced today that they have filed a patent for their new biometric secure medicine storage and retrieval system.

This revolutionary system, nicknamed "MedBox Rx," allows patients to pick up their filled prescriptions from a convenient self-serve system that could be open 24 hours a day.

The process is as simple as it is ingenious: When a customer drops off a prescription at their favorite pharmacy, the pharmacist will ask if they want to pick it up at the counter (which means possibly waiting in line and being subject to the pharmacy hours), or pick it up at the self-serve storage system – usually located immediately next to the pharmacy counter. If the customer opts to pick up their medicine from the convenient self-serve system, the pharmacist will register the patient, which is a one-time process that takes about 2-minutes. When the order is completed the pharmacist will place the medicine in a pre-determined slot in the self-service storage system. The customer can return to the store at their convenience, swipe their ID Card, place a finger in the biometric fingerprint verification system, and the appropriate slot will be able to be accessed by the customer.

Dual redundancy and military grade security assures that the proper medicine is dispensed. A proprietary software program is incorporated into each unit to track and verify each transaction.

The units are built by MedBox's manufacturing partner, AVT, Inc. in Corona, California.

"Our systems are designed to provide benefits to both the store owner and the consumer," states Vincent Mehdizadeh, Founder and CEO of MedBox. "Retailers and pharmacy owners can reduce costs by utilizing an automated self-serve solution, and customers will enjoy added convenience with no wait times. The MedBox Rx system will play a significant role in the future of pharmacy retailing and we plan on having these units either in the test phase or fully deployed at well known pharmacies nationwide within a year."

For more information on MedBox, please call the Investor Relations Department at 951-200-4137. MedBox is a publicly traded company, with its stock listed on the OTC Board, ticker symbol MDBX.

About MedBox: 

MedBox is a leader in the automated dispensing of medicines, and has offices throughout the world, including New York, Tokyo and the corporate headquarters in Los Angeles. Doctors, healthcare administrators, government regulators and patients have praised the system because it reduces abuse and medical mismanagement while it increases safety, compliance and patient convenience. The system provides accurate reports and the transaction logs cannot be modified. Limits can be set as to how much medicine the machine can dispense to patients (per day, week, month, etc.), as well as documents possible misuse or mismanagement of medicines if patients are accumulating large quantities or have potential interactions when taking more than one type of medicine.

MedBox provides their patented system and consulting services to pharmacies, clinics, hospitals, and medical groups worldwide.

Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. MedBox Medication Dispensing: Reducing Preventable ER Trips Through Better Medication Management
2. MedBox Announces Ticker Symbol Change
3. Unilife Develops Proprietary Portfolio of Wearable Subcutaneous Infusion Devices for the Self-Administration of Large Volume Drugs by Patients
4. Unilife Develops Proprietary Range of Auto-Injectors for Patient Self-Administration of Injectable Drugs
5. Unilife Develops Unifill® EZMix Multiple-Chamber Prefilled Syringes
6. Life Technologies Develops Potent Drug Delivery Technology for Therapeutics Market
7. Particle Sciences Develops Proprietary Nasal Delivery Formulation Used in Neurelis Recently Announced Successful Phase I Pharmacokinetic Study of NRL-01 (intranasal diazepam)
8. Life Technologies Develops Fast and Accurate Test to Detect Europes Deadly E. coli
9. Fuisz Pharma LLC Develops a New Generation of Oral Solid Dosage Form Shapes That Facilitate Swallowing and Esophageal Transit
10. SimQuest Develops Worlds First Platform for Open Surgical Simulation
11. JS Genetics Develops New Non-Invasive Test, XCAT-TS, to Help Doctors Diagnose Turner Syndrome
Post Your Comments:
(Date:11/26/2015)... PUNE, India , November 26, ... --> --> ... Research Report" and "Investigation Report on ... 2019 and 2021 forecasts data and ... library. . ...
(Date:11/26/2015)... Nov. 26, 2015 Research and Markets ... the "2016 Future Horizons and Growth Strategies ... Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging ... --> --> This ... the Italian therapeutic drug monitoring market, including emerging ...
(Date:11/26/2015)... , November 26, 2015 ... the addition of the  "2016 Future ... European Cell Surface Marker Testing Market: ...  report to their offering.  --> ... addition of the  "2016 Future Horizons ...
Breaking Medicine Technology:
(Date:11/26/2015)... ... November 26, 2015 , ... Pixel Film ... trailer titles with ProTrailer: Vintage. This newly styled ProTrailer pack comes with 30 ... with any font, giving users limitless opportunities to stylize and create designs quickly ...
(Date:11/25/2015)... ... , ... The holiday season is jam-packed with family dinners, ... attendees is of the utmost importance. Whether you are cooking at home for ... a try this holiday season. , Turkey Croquettes ,     Ingredients: , ...
(Date:11/25/2015)... ... November 26, 2015 , ... Ministers, senior ... (EU), ANDI Pan African Centres of Excellence, and public R&D institutions, civil societies ... the opening of the 5th African Network for Drugs and Diagnostics Innovation, ANDI, ...
(Date:11/25/2015)... ... 2015 , ... Dental professionals who would like to become more proficient on ... Dr. Mark Iacobelli’s Advanced Implant Mentoring (AIM) CE course. Courses will be held on ... co-founders of Advanced Implant Mentoring (AIM), Dr. Iacobelli and Dr. D’Orazio are proud to ...
(Date:11/25/2015)... ... ... Smiles by Stevens is pleased to announce the addition of ... patients are aware of the benefits of Botox® in the treatment of moderate facial ... discomfort, soreness, and pain as a result of Jaw Tension, TMJ (temporo-mandibular joint) disorder, ...
Breaking Medicine News(10 mins):